Ekso Bionics Inc. (EKSO)
NASDAQ: EKSO
· Real-Time Price · USD
3.09
-0.10 (-3.13%)
At close: Aug 15, 2025, 3:59 PM
3.08
-0.32%
After-hours: Aug 15, 2025, 07:16 PM EDT
Ekso Bionics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -2.71M | -2.89M | -3.41M | -2.07M | -2.42M | -3.43M | -3.21M | -3.37M | -4.23M | -4.39M | -3.18M | -4.3M | -2.98M | -4.62M | -2.86M | -1.96M | -1.27M | -3.67M |
Depreciation & Amortization | 377K | 378K | 398K | 407K | 397K | 406K | 675K | 342K | 267K | 414K | 255K | 170K | 331K | 131K | 130K | 158K | 147K | 126K |
Stock-Based Compensation | 207K | 250K | 387K | 470K | 368K | 405K | 553K | 526K | 640K | 517K | 967K | 581K | 621K | 563K | 821K | 697K | 574K | 408K |
Other Working Capital | n/a | -215K | 422K | 323K | -582K | -690K | 1.04M | 23K | 516K | 121K | 73K | 443K | -333K | -1.19M | 797K | 65K | -338K | -228K |
Other Non-Cash Items | -1.32M | 298K | 1.22M | -614K | 1.72M | 1.58M | -130K | 82K | 31K | -190K | -1.33M | 616K | -279K | 345K | 131K | 1K | 1K | 1K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -382K | 382K | n/a | n/a | n/a | n/a | n/a | n/a | -1.7M | -857K | -2.09M | 523K |
Change in Working Capital | n/a | 750K | -28K | -468K | -1.08M | -952K | 914K | -1.32M | 389K | -566K | -359K | 347K | -1.94M | -625K | 403K | -516K | -967K | 612K |
Operating Cash Flow | -3.44M | -1.97M | -1.43M | -2.28M | -2.67M | -3.47M | -1.58M | -3.35M | -2.9M | -4.21M | -3.64M | -2.59M | -4.25M | -4.21M | -3.08M | -2.48M | -3.61M | -2M |
Capital Expenditures | n/a | n/a | -21K | -8K | n/a | -8K | -43K | -17K | -55K | -42K | -53K | -141K | 175K | n/a | 1K | -60K | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 19K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -40K | -10K | n/a | n/a | n/a | n/a | -157K | n/a | n/a | n/a | -5M | n/a | n/a | n/a | -59K | n/a | n/a | n/a |
Investing Cash Flow | -40K | -10K | -21K | -8K | n/a | -8K | -43K | -17K | -55K | -42K | -5.03M | -141K | 175K | -176K | 1K | -60K | n/a | n/a |
Debt Repayment | n/a | -313K | -312K | -313K | -312K | -313K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | -226K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -62K | 3.75M | n/a | n/a | n/a | n/a | -313K | n/a | n/a | n/a | n/a | n/a | n/a | -176K | n/a | n/a | n/a | 1.42M |
Financial Cash Flow | 616K | 3.53M | -314K | 4.69M | -265K | 3.66M | 348K | n/a | n/a | n/a | 176K | n/a | 176K | 176K | n/a | n/a | n/a | 38.71M |
Net Cash Flow | -2.81M | 1.56M | -1.8M | 2.41M | -2.91M | 161K | -1.3M | -3.37M | -2.97M | -4.25M | -8.65M | -2.73M | -4.26M | -4.23M | -3.03M | -2.5M | -3.6M | 36.68M |
Free Cash Flow | -3.44M | -1.97M | -1.45M | -2.29M | -2.67M | -3.47M | -1.63M | -3.37M | -2.96M | -4.26M | -3.7M | -2.73M | -4.07M | -4.21M | -3.07M | -2.54M | -3.61M | -2M |